BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 18, 2009
View Archived Issues
Apoptosis inducers in early development at Chinese Academy of Medical Science
Read More
AstraZeneca reports second quarter 2009 results
Read More
VAK-694 safety and tolerability to be assessed by Novartis in allergic rhinitis phase II trial
Read More
Gilead presents studies of its pharmaco-enhancer GS-9350 in the treatment of HIV
Read More
Xinchang Pharmaceutical Factory claims novel anticancer compounds
Read More
Merz discloses mGluR5 modulators for the treatment of pain
Read More
Sativex is well tolerated and improves spasticity due to multiple sclerosis in clinical trial
Read More
ACE-011 active against bone loss in postmenopausal women
Read More
TBR-652 in vitro activity in combination with antiretrovirals and human pharmacokinetics reported
Read More
Botulinum toxin type A improves various Parkinson's disease symptoms
Read More
ONO-5334 shows potential for osteoporosis therapy in ovariectomized monkeys
Read More
Cell Therapeutics reports 18-month follow-up data from phase III pixantrone study
Read More
Biovex and FDA agree on design for pivotal phase III OncoVEX(GM-CSF) study
Read More
Cytavis initiates phase II aviscumine trial in metastatic colorectal carcinoma
Read More
DNage initiates observational study in children with Cockayne syndrome
Read More
EMEA recommends orphan drug designation of intravenous CP-4126 for pancreatic cancer
Read More
European Commission approves expanded use for raltegravir in adults with HIV
Read More
FDA clears D3 FastPoint L-DFATM respiratory virus identification kit
Read More
Hyperion Therapeutics enrolls first patient in HPN-100 trial in children with urea cycle disorders
Read More
Lexicon initiates phase II trial of LX-4211 in type 2 diabetes
Read More
Poniard presents update on pivotal phase III picoplatin trial in lung cancer
Read More
FDA grants orphan drug designation to Restanza for plague and tularemia
Read More
RX-100 shows potential in protecting against lethal whole-body radiation
Read More
ZaBeCor begins phase II Excellair trial in asthma patients
Read More
Seaside Therapeutics secures funding to support studies in autism and fragile X syndrome
Read More
FDA approves Valturna, a single-pill combination of aliskiren and valsartan
Read More
